{"id":"af791bbb-c3b4-4628-bfe7-8404c754dd09","name":"B-TEMIA","slug":"b-temia","description":"Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Its flagship product [Keeogo](/models/btemia-keeogo) is a powered lower-limb exoskeleton that provides motorized knee assistance for stroke patients and individuals with mobility impairments in rehabilitation settings. B-TEMIA received FDA 510(k) clearance for Keeogo in September 2020 and was acquired by Wistron Medical Tech Holding Company in 2025 through a court-approved stalking horse agreement following insolvency proceedings","status":"acquired","founded":2010,"hq":"Saint-Augustin-de-Desmaures, Quebec, Canada","hqLat":46.8137431,"hqLng":-71.2084061,"hqGeocodedAt":"2026-08-05T14:21:03.778Z","hqAddress":null,"hqPrecision":null,"website":"https://www.b-temia.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":54,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA","sourceName":"B-TEMIA (primary)"},{"url":"https://b-temia.com/","title":"B-TEMIA (official)","sourceName":"B-TEMIA (primary)"},{"url":"https://ised-isde.canada.ca/site/investment-canada-act/en/node/233015","title":"Case 00036855 - Investment Canada Act","sourceName":"Government of Canada","publishedAt":"2025-05-12"}],"keyFacts":[{"label":"HQ","value":"Saint-Augustin-de-Desmaures, Quebec, Canada"},{"label":"Founded","value":"2010"},{"label":"Leadership","value":"CEO David Quitman; founder Stéphane Bédard was CEO until Sep 2023."},{"label":"Product","value":"Keeogo powered Dermoskeleton for mobility assistance."},{"label":"FDA","value":"510(k) clearance for Keeogo (K201539), Sep 2020."},{"label":"Funding (reported, unconfirmed)","value":"About $11M total; investors include CED Quebec and Epic Capital."},{"label":"Acquisition (reported, 2025)","value":"Bought by Wistron Medical Tech Holding after Dec 2024 insolvency proceedings."},{"label":"US distribution (reported, May 2024)","value":"DIH Holding US got exclusive Keeogo rights in Canada, US and Mexico."},{"label":"Asia","value":"B-Temia Asia, a Wistron JV, holds a Taiwan TFDA license."}],"aliases":["B-TEMIA Inc"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T02:05:05.191Z","updatedAt":"2026-10-12T22:42:22.418Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/b-temia","url":"https://registry.deploy.report/companies/b-temia","name":"B-TEMIA","alternateName":["B-TEMIA Inc"],"description":"Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Its flagship product [Keeogo](/models/btemia-keeogo) is a powered lower-limb exoskeleton that provides motorized knee assistance for stroke patients and individuals with mobility impairments in rehabilitation settings. B-TEMIA received FDA 510(k) clearance for Keeogo in September 2020 and was acquired by Wistron Medical Tech Holding Company in 2025 through a court-approved stalking horse agreement following insolvency proceedings","identifier":"af791bbb-c3b4-4628-bfe7-8404c754dd09","foundingDate":"2010","address":"Saint-Augustin-de-Desmaures, Quebec, Canada","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":[]}}}